Status:
UNKNOWN
Study of the Pronostic Impact of Immunohistochemical, Histological and Radiological Factors in Patients With Primary Central Nervous System Lymphoma.
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Rare Disease With Poor Outcome
Eligibility:
All Genders
21+ years
Brief Summary
Primary Central Nervous System Lymphoma (PCNSL) have a specific mutational profile in comparison to systemic diffuse large cells lymphoma (DLBCLs) that can be related to the expression of immunohistoc...
Eligibility Criteria
Inclusion
- PCNSL diagnosed between January 2011 and December 2019, without regard to the clinical outcome.
- Age \> 18
Exclusion
- Systemic DLBCL
Key Trial Info
Start Date :
April 20 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2022
Estimated Enrollment :
94 Patients enrolled
Trial Details
Trial ID
NCT05347511
Start Date
April 20 2022
End Date
September 1 2022
Last Update
April 26 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.